These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2732683)

  • 41. Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies.
    Lafon M; Ideler J; Wunner WH
    Dev Biol Stand; 1984; 57():219-25. PubMed ID: 6084612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of P gene-deficient rabies virus: propagation, pathogenicity and antigenicity.
    Morimoto K; Shoji Y; Inoue S
    Virus Res; 2005 Jul; 111(1):61-7. PubMed ID: 15896403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of mutation on the virulence in mice of a strain of foot-and-mouth disease virus.
    McCahon D; Slade WR; King AM; Saunders K; Pullen L; Lake JR; Priston RA
    J Gen Virol; 1981 Jun; 54(Pt 2):263-72. PubMed ID: 6270249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. e. Infection defense antigens of rabies virus and genetic code].
    Kawai A; Ohkubo A; Morimoto K
    Nihon Rinsho; 1987 Oct; 45(10):2252-7. PubMed ID: 3448264
    [No Abstract]   [Full Text] [Related]  

  • 45. Multidisciplinary approach to epizootiology and pathogenesis of bat rabies viruses in the United States.
    Ellison JA; Johnson SR; Kuzmina N; Gilbert A; Carson WC; VerCauteren KC; Rupprecht CE
    Zoonoses Public Health; 2013 Feb; 60(1):46-57. PubMed ID: 23137052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutation in NS5 protein attenuates mouse neurovirulence of yellow fever 17D vaccine virus.
    Xie H; Ryman KD; Campbell GA; Barrett AD
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1895-9. PubMed ID: 9714237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
    Wang Y; Rowley KJ; Booth BJ; Sloan SE; Ambrosino DM; Babcock GJ
    Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of rabies virus mimotopes screened from a phage display peptide library with purified dog anti-rabies virus serum IgG.
    Yang L; Cen J; Xue Q; Li J; Bi Y; Sun L; Liu W
    Virus Res; 2013 Jun; 174(1-2):47-51. PubMed ID: 23499997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single amino acid change at position 255 in rabies virus glycoprotein decreases viral pathogenicity.
    Luo J; Zhang B; Lyu Z; Wu Y; Zhang Y; Guo X
    FASEB J; 2020 Jul; 34(7):9650-9663. PubMed ID: 32469133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Progress about genetic and variant study of rabies virus glycoprotein gene].
    Tao XY; Tang Q
    Bing Du Xue Bao; 2011 Mar; 27(2):184-8. PubMed ID: 21528545
    [No Abstract]   [Full Text] [Related]  

  • 51. The molecular biology of rabies viruses.
    Wunner WH; Larson JK; Dietzschold B; Smith CL
    Rev Infect Dis; 1988; 10 Suppl 4():S771-84. PubMed ID: 2462742
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Properties of the rabies virus long persisting in cell cultures].
    Bogomolova NN; Boriskin IuS; Bektemirova MS; Ianova NN; Matevosian KSh
    Vopr Virusol; 1980; (3):315-8. PubMed ID: 7434724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation.
    Lafay F; Coulon P; Astic L; Saucier D; Riche D; Holley A; Flamand A
    Virology; 1991 Jul; 183(1):320-30. PubMed ID: 2053286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amino acid substitution at position 95 in rabies virus matrix protein affects viral pathogenicity.
    Ito N; Mita T; Shimizu K; Ito Y; Masatani T; Nakagawa K; Yamaoka S; Abe M; Okadera K; Minamoto N; Sugiyama M
    J Vet Med Sci; 2011 Oct; 73(10):1363-6. PubMed ID: 21646750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure of the glycoprotein gene in rabies virus.
    Anilionis A; Wunner WH; Curtis PJ
    Nature; 1981 Nov; 294(5838):275-8. PubMed ID: 6272128
    [No Abstract]   [Full Text] [Related]  

  • 56. Biochemical characterization of temperature-sensitive rabies virus mutants.
    Saghi N; Flamand A
    J Virol; 1979 Jul; 31(1):220-30. PubMed ID: 387977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolation of temperature-sensitive conditional lethal mutants of "fixed" rabies virus.
    Clark HF; Koprowski H
    J Virol; 1971 Mar; 7(3):295-300. PubMed ID: 5550101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amino acid composition and terminal sequence analysis of the rabies virus glycoprotein: identification of the reading frame on the cDNA sequence.
    Lai CY; Dietzschold B
    Biochem Biophys Res Commun; 1981 Nov; 103(2):536-42. PubMed ID: 7332557
    [No Abstract]   [Full Text] [Related]  

  • 59. Neuronal cell surface molecules mediate specific binding to rabies virus glycoprotein expressed by a recombinant baculovirus on the surfaces of lepidopteran cells.
    Tuffereau C; Benejean J; Alfonso AM; Flamand A; Fishman MC
    J Virol; 1998 Feb; 72(2):1085-91. PubMed ID: 9445003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Reverse genetics of rabies virus and its applications].
    Du JL; Tang Q
    Bing Du Xue Bao; 2008 Nov; 24(6):478-82. PubMed ID: 19226958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.